Gastrointestinal Drugs Market
                     Gastrointestinal Drugs Market
 
Gastrointestinal Drugs Market Forecast 
to 2027 - COVID-19 Impact and Global 
Analysis by Drug Class (Acid 
Neutralizers, Antidiarrheal and 
Laxatives, Anti-Inflammatory Drugs, 
Antiemetic and Antinauseants, 
Biologics, Others); Route of 
Administration (Oral, Parenteral); 
Application (Inflammatory Ulcerative 
Colitis, Crohn's Disease, Irritable Bowel 
Syndrome, Gastroenteritis, Celiac 
Disease, Others); Distribution Channel 
(Hospital Pharmacies, Retail 
Pharmacies, and Online Pharmacies), 
and Geography
Hemophilia Treatment Market 
Current and future Market Scenario
 According to our new market research study on “Gastrointestinal Drugs Market Forecast to 2027 – COVID-19 
Impact and Global Analysis – by Drug Class, Route of Administration, Application, and Distribution Channel,” 
the market is expected to reach US$ 71,300.28 million in 2027 from US$ 49,043.38 million in 2019.
  The market is estimated to grow at a CAGR of 4.9% from 2020 to 2027. The report highlights trends 
prevailing in the market, and drivers and hindrances pertaining to the market growth.
 Based on drug class, the market is segmented in to acid neutralizers, antidiarrheal and laxatives, anti-
inflammatory drugs, antiemetic and antinauseants, biologics, and others.. 
 In 2019, the acid neutralizers segment held the largest share of the market. The biologics segment is 
expected to grow at the fastest CAGR during the forecast period. The advent of biologics has had a 
significant impact on the management of inflammatory bowel disease (IBD). 
 Treatment with biologics has led to an improved quality of life for patients living with Crohn's disease and 
ulcerative colitis, with fewer admissions to the hospital and less side effects from corticosteroids. 
Key Findings
 These are the most recently developed treatments for IBD. Biologic therapies are indicated for people 
with moderately to severely active disease who have not responded well to conventional therapy. Four of 
these agents (adalimumab, certolizumab pegol, golimumab and infliximab) target an inflammatory protein 
called tumor necrosis factor (TNF). Natalizumab and vedolizumab work by blocking certain types of white 
blood cells from getting into inflamed tissues.
 Market Insights
Rise in Prevalence of Gastrointestinal (GI) Diseases
Gastrointestinal diseases are the conditions that occur in the gastrointestinal tract. Common digestive 
problems include heartburn, inflammatory bowel diseases (IBD), inflammatory bowel syndrome (IBS), 
constipation, and diarrhea. GI diseases account for substantial health care utilization and spending. 
According to the European Federation of Crohn's & Ulcerative Colitis Associations (EFCCA), around 10 million 
people are living with IBD worldwide. Growing prevalence of IBD can be ascribed to poor nutritional choices, 
including a high intake of ultra-processed foods and trans-fats.
 
Hemophilia Treatment Market 
 
Market Segments
By Drug Class  
Acid Neutralizers
Antidiarrheal and Laxatives By Route of By Application
Anti-Inflammatory Drugs Administration                        Inflammatory Ulcerative Colitis
Antiemetic and Antinauseants     Crohn's Disease
Biologics Oral Irritable Bowel Syndrome
Others Parenteral Gastroenteritis
Celiac Disease
Others
Hemophilia Treatment Market 
Dominating Segments
 
 Drug Class-BasedInsights                                    
 
Based on drug class, the gastrointestinal drugs market is segmented into acid neutralizers, antidiarrheal and 
laxatives, anti-inflammatory drugs, antiemetic and antinauseants, biologics, and others. In 2019, the acid 
neutralizerssegment accounted for the highest share of the market. Growth of this segment is attributed to 
increasing incidence of GERD and rising patient pool across the globe. However, the biologicssegment likely to 
register the highest CAGR in the global gastrointestinal drugsmarket during the forecast period.
 Route of Administration-Based Insights
In terms ofroute of administration, the gastrointestinal drugsmarket is segmented into oral and parenteral. The 
oral segment held the largest share of the market in 2019, whereas the same segment is estimated to register 
the highest CAGR of 5.2% in the market during the forecast period.
Dominating Segments
 Application-BasedInsights
Based on application, the gastrointestinal drugsmarket is segmented into inflammatory ulcerative colitis, Crohn's disease, irritable 
bowel syndrome, gastroenteritis, celiac disease, and others. The inflammatory ulcerative colitissegment held the largest share of 
the market in 2019, whereas the irritable bowel syndromesegment is projected to register the highest CAGR of 5.8% in the market 
during the forecast period.
 Distribution Channel-Based Insights
In terms ofdistribution channel, the gastrointestinal drugsmarket is segmented into retail pharmacies, hospital pharmacies, and 
online pharmacies. The retail pharmaciessegment held the largest share of the market in 2019, and same segment is expected to 
register the highest CAGR of 5.4% in the market during the forecast period.    
 Download PDF Brochure https://www.theinsightpartners.com/sample/TIPRE00014758/
Dominating Segments
 The report segments global gastrointestinal drugs market as follows:
 
 By Drug Class
 Acid Neutralizers
 Antidiarrheal and Laxatives
 Anti-Inflammatory Drugs
 Antiemetic and Antinauseants
 Biologics
 Others
 By Route of Administration
 Oral
 Parenteral
Dominating Segments
 By Application
 Inflammatory Ulcerative Colitis
 Crohn's Disease
 Irritable Bowel Syndrome
 Gastroenteritis
 Celiac Disease
 Others
 By Distribution Channel
 Hospital Pharmacies
 Retail Pharmacies
 Online Pharmacies
Hemophilia Treatment Market  
Leading Players
 Company Profiles
 Sanofi
 GlaxoSmithKline plc
 Johnson and Johnson Services, Inc.
 Bausch Health
 AstraZeneca
 Takeda Pharmaceutical Company Limited
 AbbVie Inc.
 Bayer AG
 Celltrion Healthcare Co., Ltd.
 LEXICON PHARMACEUTICALS, INC
  REGIONAL FRAMEWORK
REGIONAL FRAMEWORK
  Hemophilia Treatment Market  
 
 
 Hemophilia Treatment Market 
 
 
        
Access Full Research Report at: 
https://www.theinsightpartners.com/reports/gastrointestinal-drugs-market/
Thank You! 
 Thank You!